A Reappraisal of Women’s Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50–59 Years of Age
The Women’s Health Initiative (WHI) Estrogen-Alone Trial randomized postmenopausal women, 50 to 79 years of age, with prior hysterectomy, to conjugated equine estrogens (CEE) or placebo with a 5.9-year median duration of CEE use. In 2013, the WHI published outcomes for additional extended follow-up....
Saved in:
Main Author: | Eric Roehm |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Obstetrics and Gynecology International |
Online Access: | http://dx.doi.org/10.1155/2015/713295 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of Osteoporosis in Women Over 50 Years of Age: Preventive and Therapeutic Management Skills
by: Enrique Rodríguez Reyes, et al.
Published: (2023-10-01) -
Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years
by: Frederik K. Palshof, et al.
Published: (2025-02-01) -
Exercise intensity and reliability during recreational team
handball training for 50–77-year-old unexperienced women
by: Rita Pereira, et al.
Published: (2024-05-01) -
Reappraisal and neotypification of Phyllachora feijoae
by: L.C. Costa, et al.
Published: (2012-06-01) -
The Rapid Effect of Bisphenol-A on Long-Term Potentiation in Hippocampus Involves Estrogen Receptors and ERK Activation
by: Xiaowei Chen, et al.
Published: (2017-01-01)